Session Information
14th Annual Green Chemistry and Engineering Conference
Click here to go to the previous page
Key green engineering research areas of pharmaceuticals and fine chemicals - A perspective from manufacturers
Track : June 22, 2010
Program Code: 073
Date: Tuesday, June 22, 2010
Time: 12:00 PM to 12:20 PM  EST
Location: Capital Hilton - Federal A
CONTRIBUTOR (S):
Raf Reintjens, DSM Innovative Synthesis B.V., Geleen, The Netherlands
Vivianne Massonneau, Merck, United States
Rinus Broxterman, DSM, Austria
Henk Noorman, DSM, Austria
Peter Poechlauer, DSM, Austria
James Baird, Astra Zeneca, United Kingdom
Hsien-Hsin Tung, Abbott, United States
Philip Dell''Orco, Sustainability and Environment, GlaxoSmithKline, RTP, NC, United States
Robert Hannah, Sustainability and Environment, GlaxoSmithKline, RTP, NC, United States
Carl Bertsch, Lilly, United States
Ayman Allian, Abbott, United States
David am Ende, Pfizer, United States
Bing-Shiou Yang, Boehringer Ingelheim, United States
Alex Chu-Kung, Abbott, United States
SPEAKER :
Jiminez Gonzalez, Sustainability and Environment, GlaxoSmithKline, RTP, NC, United States
Description
In 2005, the ACS Green Chemistry Institute (GCI) and the global pharmaceutical corporations developed the ACS GCI Pharmaceutical Roundtable (ACS GCI PR) to encourage the integration of Green Chemistry and Green Engineering into the pharmaceutical industry.

The Roundtable has developed a list of key research areas in Green Chemistry in 2007 and now is followed by a list of key research areas in Green Engineering. This presentation will summarize the proposed key research Green Engineering research areas from the veiwpoint of the ACS GCI PR, provide an assessment of the current state of the art and highlight challenges and future perspectives.


Audio Synchronized to PowerPoint
View